Brief: Onxeo announces positive preclinical proof of concept results for AsiDNA
July 5 (Reuters) - ONXEO SA C4X.PA :
* ONXEO ANNOUNCES POSITIVE PRECLINICAL PROOF OF CONCEPT
RESULTS CONFIRMING ASIDNA ACTIVITY VIA SYSTEMIC ADMINISTRATION
* STRONG DATA CONFIRMS NEAR-TERM PLAN TO INITIATE CLINICAL
TRIAL FOR ASIDNA
SOURCE TEXT FOR EIKON: ID:nBw2N9CPba
FURTHER COMPANY COVERAGE: C4X.PA
(Gdynia Newsroom:)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln